MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-24-2026
Medtronic PLC Gross Profit 2011-2026 | MDT
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 19.6 B | 21.5 B | 20.9 B | 20.4 B | 19.7 B | 14 B | 12.7 B | 12.5 B | 12.3 B | 12 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.5 B | 12 B | 16.6 B |
Quarterly Gross Profit Medtronic PLC
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.32 B | - | - | 3.73 B | 5.28 B | 5.31 B | 5.13 B | 5.66 B | 5.18 B | 5.28 B | 5.18 B | 5.75 B | 5.02 B | 4.93 B | 5.04 B | 5.48 B | 4.79 B | 5.02 B | 4.9 B | 5.2 B | 3.19 B | 4.88 B | 4.82 B | 4.37 B | 3.11 B | 3.22 B | 3.17 B | 3.4 B | - | 3.1 B | 3.06 B | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.75 B | 3.06 B | 4.59 B |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.8 B | $ 186.73 | 1.1 % | $ 14 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
89.3 M | $ 12.67 | -0.78 % | $ 1.71 B | USA |
 |
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | USA |
 |
Inogen
INGN
|
154 M | $ 6.33 | -0.2 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
19.2 M | $ 1.02 | -0.97 % | $ 17.3 M | USA |
 |
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
342 M | $ 296.75 | 1.55 % | $ 8.37 B | USA |
 |
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
26.6 M | $ 3.44 | 4.24 % | $ 129 M |  France |
 |
Bruker Corporation
BRKR
|
1.65 B | $ 40.46 | 1.4 % | $ 6.03 K | USA |
 |
LENSAR
LNSR
|
14.1 M | $ 6.2 | 2.57 % | $ 74.1 M | USA |
 |
Boston Scientific Corporation
BSX
|
13.9 B | $ 64.31 | 0.77 % | $ 95.2 B | USA |
 |
Cytosorbents Corporation
CTSO
|
26.5 M | $ 0.58 | -0.85 % | $ 36.1 M | USA |
 |
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
61 K | $ 1.99 | 0.51 % | $ 1.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 10.51 | 1.25 % | $ 298 M | USA |
 |
Myomo
MYO
|
26.9 M | $ 0.79 | 0.09 % | $ 33.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
50 M | $ 25.65 | 1.75 % | $ 217 M | USA |
 |
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
461 K | $ 2.8 | - | $ 7.77 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
1.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
719 M | $ 94.84 | -0.11 % | $ 12.8 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
173 M | $ 18.34 | 2.69 % | $ 430 M | USA |
 |
Butterfly Network
BFLY
|
48.8 M | $ 4.82 | 8.45 % | $ 1.02 B | USA |
 |
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | USA |
 |
Tactile Systems Technology
TCMD
|
250 M | $ 25.36 | 1.2 % | $ 580 M | USA |
 |
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
73.4 M | $ 10.92 | 0.37 % | $ 391 M | USA |
 |
Tandem Diabetes Care
TNDM
|
167 M | $ 21.36 | 1.18 % | $ 1.45 B | USA |
 |
Inspire Medical Systems
INSP
|
779 M | $ 57.94 | 1.95 % | $ 1.7 B | USA |
 |
CONMED Corporation
CNMD
|
750 M | $ 39.42 | -0.78 % | $ 1.22 B | USA |
 |
LivaNova PLC
LIVN
|
940 M | $ 65.51 | 0.8 % | $ 3.57 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
500 M | $ 87.56 | -1.21 % | $ 3.04 B | USA |
 |
FONAR Corporation
FONR
|
42.4 M | $ 18.75 | -0.05 % | $ 123 M | USA |